← Back to Search

Smoke-Free Housing Strategies for Secondhand Smoke Exposure

N/A
Waitlist Available
Led By Vaughan Rees, PhD
Research Sponsored by Harvard School of Public Health (HSPH)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention through 6 months post intervention
Awards & highlights

Study Summary

This trial studies how to implement smoke-free housing that meets the needs of residents in Permanent Supportive Housing. It looks to refine an implementation framework with behavioral health support.

Who is the study for?
This trial is for adults living in six specific affordable housing communities, whether they smoke or not. It includes residents receiving support services and property managers or their appointees who can engage in English interviews. Caseworkers providing behavioral health support are also eligible. Non-English or non-Spanish speakers cannot participate.Check my eligibility
What is being tested?
The study tests a framework and toolkit designed to help implement smoke-free policies in Permanent Supportive Housing. It aims to see if these tools are acceptable, feasible, and effective by gathering feedback from various stakeholders involved.See study design
What are the potential side effects?
Since this trial involves policy implementation rather than medication, there aren't direct side effects like those associated with drugs. However, participants may experience stress or discomfort when discussing smoking habits or changes due to the new smoke-free policies.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention through 6 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-intervention through 6 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Intervention Measure (AIM)
Feasibility of Intervention Measure (FIM)
Secondary outcome measures
Ambient second-hand smoke in common indoor areas
Behavior of residents who smoke
Residents' self-reported exposure to secondhand smoke

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All participants will receive the intervention of the Smokefree Implementation Framework and Toolkit

Find a Location

Who is running the clinical trial?

Harvard School of Public Health (HSPH)Lead Sponsor
272 Previous Clinical Trials
16,304,532 Total Patients Enrolled
Beacon CommunitiesUNKNOWN
The Community BuildersUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people still eligible to enroll in this experimental program?

"According to the details available on clinicaltrials.gov, this experiment is no longer recruiting applicants. Although registration for this trial closed after its September 13th 2023 edit date, there are still 200 different studies looking for participants today."

Answered by AI
~320 spots leftby Sep 2025